Search Orphan Drug Designations and Approvals
-
| Generic Name: | synthetic 14-mer phosphorothioate antisense oligonucleotide directed against TGF-beta2 mRNA |
|---|---|
| Date Designated: | 06/04/2015 |
| Orphan Designation: | Prevention of scarring post glaucoma filtration surgery |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Isarna Therapeutics GmbH Leopoldstrasse 254-256 D-80807 Munich Munich Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







